P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer
Dr Alessandro Crocoli speaks to ecancer about a 15-year retrospective study examining difficult central venous catheter removal in children.
He reports that difficult removal was rare, occurring in less than 1% of more than 3,000 procedures, and was particularly associated with prolonged catheter dwell times and chronic disease.
Dr Crocoli explains that almost half of the difficult cases resulted in a retained catheter fragment, with affected patients managed conservatively without subsequent late complications.
He highlights a shift from aggressive attempts at complete extraction towards a more conservative approach, suggesting that leaving retained intravascular fragments in place may be a safe option for selected asymptomatic patients when standard catheter removal fails.
P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer
First-in-human study of in vivo CAR-T therapy shows promising activity in relapsed or refractory B-cell non-Hodgkin lymphoma
Durvalumab plus chemotherapy improves survival in extensive-stage small cell lung cancer regardless of tumour laterality
Ultra-sensitive ctDNA detects residual disease and predicts recurrence early in RCC
Pirtobrutinib significantly improves PFS in treatment-naïve CLL/SLL compared to bendamustine plus rituximab
Longer follow-up shows promising PFS + MRD negativity for mosunetuzumab use in untreated high tumour burden follicular lymphoma
Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations
Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast cancer